Provided by Tiger Trade Technology Pte. Ltd.

Nuvation Bio, Inc.

5.14
-0.4200-7.55%
Post-market: 5.230.0900+1.75%19:57 EDT
Volume:14.83M
Turnover:78.11M
Market Cap:1.80B
PE:-11.72
High:5.66
Open:5.66
Low:5.03
Close:5.56
52wk High:9.75
52wk Low:3.36
Shares:351.12M
Float Shares:264.00M
Volume Ratio:3.80
T/O Rate:5.62%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4387
EPS(LYR):-0.6000
ROE:-47.81%
ROA:-12.36%
PB:7.11
PE(LYR):-8.57

Loading ...

Nuvation Bio reports results from TRUST-I and TRUST-II trials for IBTROZI

TIPRANKS
·
Apr 22

Nuvation Bio publishes corporate presentation on IBTROZI launch, oncology pipeline updates

Reuters
·
Apr 22

Nuvation Bio says pooled TRUST data show 49.7-month IBTROZI response duration

Reuters
·
Apr 22

Nuvation Bio Chief Regulatory Officer Kerry Wentworth sells 36,750 shares for $184,279

Reuters
·
Apr 22

Nuvation Bio CMO Liu Dongfang disposes 50,000 common shares for $251,000

Reuters
·
Apr 22

Nuvation Bio publishes 2025 annual report to stockholders

Reuters
·
Apr 21

Nuvation Bio schedules first-quarter financial results call and webcast

Reuters
·
Apr 21

Nuvation Bio to Report First Quarter 2026 Financial Results and Provide Business Update on May 4, 2026

THOMSON REUTERS
·
Apr 21

A Look At Nuvation Bio’s Valuation As Ibtrozi Uptake And Q1 Earnings Expectations Gain Attention

Simply Wall St.
·
Apr 18

Nuvation Bio's Ibtrozi Gains Frontline Momentum Ahead of Key Q1 Print, Wedbush Says

MT Newswires Live
·
Apr 16

Nuvation Bio Price Target Maintained With a $11.00/Share by Wedbush

Dow Jones
·
Apr 16

Nuvation Bio (NUVB) Gets a Buy from Wedbush

TIPRANKS
·
Apr 16

Nuvation Bio announces annual shareholder meeting via webcast

Reuters
·
Apr 10

Nuvation Bio Chief Regulatory Officer Kerry Wentworth disposes 200,000 shares for $903,560

Reuters
·
Apr 09

RBC Capital Sticks to Their Buy Rating for Nuvation Bio (NUVB)

TIPRANKS
·
Apr 08

JonesTrading Sticks to Their Buy Rating for Nuvation Bio (NUVB)

TIPRANKS
·
Apr 07

RBC Raises Price Target on Nuvation Bio to $20 From $13, Keeps Outperform, Speculative Risk

MT Newswires Live
·
Apr 06

Nuvation Bio Inc : RBC Raises Target Price to $20 From $13

THOMSON REUTERS
·
Apr 06

U.S. RESEARCH ROUNDUP-EQT, Las Vegas Sands, Twilio

Reuters
·
Apr 06

Is EMA Validation Of Taletrectinib Expanding Nuvation Bio’s (NUVB) Targeted Lung Cancer Opportunity?

Simply Wall St.
·
Apr 04